Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
Background: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants. Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To a...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-05-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S201325141500022X |
id |
doaj-12641cfdb4354a91983fb229d40df1b0 |
---|---|
record_format |
Article |
spelling |
doaj-12641cfdb4354a91983fb229d40df1b02020-11-25T00:47:51ZengElsevierNefrología (English Edition)2013-25142015-05-0135329630310.1016/j.nefroe.2015.06.003Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologiesLeonor Bardallo Cruzado0Elena Pérez González1Zoraima Martínez Martos2Carmen Bermudo Guitarte3Mercedes Granero Asencio4Salud Luna Lagares5Mariano Marín Patón6Juan Polo Padilla7UGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUnidad de Nefrología Pediátrica, UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Bioquímica Clínica, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUGC Neonatología, Hospital Universitario Virgen Macarena, Sevilla, SpainUnidad de Nefrología Pediátrica, UGC de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, SpainDepartamento de Bioestadística, Universidad de Sevilla, Sevilla, SpainBackground: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants. Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To analyse alterations caused by prematurity diseases. Method: The design involved a longitudinal, observational study of prospective cohorts. Groups were based on gestational age (GA): Group A (24–27 weeks), Group B (28–33 weeks), Group C (34–36 weeks). Blood samples were collected at birth, within 48–72 h and after 7 days of life. Statistics: SPSS v.20 software was used. The statistical methods applied included chi-squared test and ANOVA. Results: A total of 109 preterm infants were included in the study. CysC levels were 1.54 mg/l (±0.28) at birth, 1.38 mg/l (±0.36) within 48–72 h of life, and 1.50 mg/l (± 0.31) after 7 days (p < 0.05). Cr levels were 0.64 mg/dl (±0.17) at birth, 0.64 mg/dl (± 0.28) within 48–72 h, and 0.56 mg/dl (± 0.19) after 7 days (P < .05). CysC values were lower in hypotensive patients and in those with a respiratory disease (P < .05), and no alterations associated with other diseases were observed. There were no differences in Cr levels associated with any disease. Creatinine levels were higher in patients ≤1.500 g (P < .05). Conclusions: Serum CysC decreased within 48–72 h of life, and this decline showed significance (P < .05). The levels increased after 7 days in all 3 GA groups, and there was no difference in CysC levels among the groups. More studies in preterm infants with hypotension and respiratory disease are required. CysC is a better glomerular filtration rate (GFR) marker in ≤1.500 g preterm infants.http://www.sciencedirect.com/science/article/pii/S201325141500022XCystatin CCreatininePremature infant |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leonor Bardallo Cruzado Elena Pérez González Zoraima Martínez Martos Carmen Bermudo Guitarte Mercedes Granero Asencio Salud Luna Lagares Mariano Marín Patón Juan Polo Padilla |
spellingShingle |
Leonor Bardallo Cruzado Elena Pérez González Zoraima Martínez Martos Carmen Bermudo Guitarte Mercedes Granero Asencio Salud Luna Lagares Mariano Marín Patón Juan Polo Padilla Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies Nefrología (English Edition) Cystatin C Creatinine Premature infant |
author_facet |
Leonor Bardallo Cruzado Elena Pérez González Zoraima Martínez Martos Carmen Bermudo Guitarte Mercedes Granero Asencio Salud Luna Lagares Mariano Marín Patón Juan Polo Padilla |
author_sort |
Leonor Bardallo Cruzado |
title |
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies |
title_short |
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies |
title_full |
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies |
title_fullStr |
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies |
title_full_unstemmed |
Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies |
title_sort |
serum cystatin c levels in preterm newborns in our setting: correlation with serum creatinine and preterm pathologies |
publisher |
Elsevier |
series |
Nefrología (English Edition) |
issn |
2013-2514 |
publishDate |
2015-05-01 |
description |
Background: Cystatin C (CysC) is a renal function marker that is not as influenced as creatinine (Cr) by endogenous or exogenous agents, so it is proposed as a marker in preterm infants.
Objectives: To determine serum CysC values in preterm infants during the first week of life, compared to Cr. To analyse alterations caused by prematurity diseases.
Method: The design involved a longitudinal, observational study of prospective cohorts.
Groups were based on gestational age (GA): Group A (24–27 weeks), Group B (28–33 weeks), Group C (34–36 weeks). Blood samples were collected at birth, within 48–72 h and after 7 days of life.
Statistics: SPSS v.20 software was used. The statistical methods applied included chi-squared test and ANOVA.
Results: A total of 109 preterm infants were included in the study. CysC levels were 1.54 mg/l (±0.28) at birth, 1.38 mg/l (±0.36) within 48–72 h of life, and 1.50 mg/l (± 0.31) after 7 days (p < 0.05). Cr levels were 0.64 mg/dl (±0.17) at birth, 0.64 mg/dl (± 0.28) within 48–72 h, and 0.56 mg/dl (± 0.19) after 7 days (P < .05). CysC values were lower in hypotensive patients and in those with a respiratory disease (P < .05), and no alterations associated with other diseases were observed. There were no differences in Cr levels associated with any disease. Creatinine levels were higher in patients ≤1.500 g (P < .05).
Conclusions: Serum CysC decreased within 48–72 h of life, and this decline showed significance (P < .05). The levels increased after 7 days in all 3 GA groups, and there was no difference in CysC levels among the groups. More studies in preterm infants with hypotension and respiratory disease are required. CysC is a better glomerular filtration rate (GFR) marker in ≤1.500 g preterm infants. |
topic |
Cystatin C Creatinine Premature infant |
url |
http://www.sciencedirect.com/science/article/pii/S201325141500022X |
work_keys_str_mv |
AT leonorbardallocruzado serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT elenaperezgonzalez serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT zoraimamartinezmartos serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT carmenbermudoguitarte serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT mercedesgraneroasencio serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT saludlunalagares serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT marianomarinpaton serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies AT juanpolopadilla serumcystatinclevelsinpretermnewbornsinoursettingcorrelationwithserumcreatinineandpretermpathologies |
_version_ |
1725258168337956864 |